Chlorophyll a, the major green pigment of the plant world, is certainly the most widespread and conspicuous of organic natural products. Few can be unaware of its decorative function, and all are beneficiaries of its central role in transforming sunlight into substance and sustenance. Yet the fruitful chemical study of this green badge of life did not commence until fairly recent times. For chlorophyll a is a very reactive, sensitive, and complicated substance. Only when, early in this century, the genius of Willstatter applied itself to the problem, were the first sure steps taken. That great investigator isolated the pigment-and its closely related frequent minor concomitant chlorophyll b as well-in the pure state, established correctly the empirical formula of the substance, and laid down a sound and extensive preliminary basis of transformation and degradation. These achievements can be measured against the fact that the isolation of chlorophyll in a state of purity is even now, after more than fifty years, no mean feat, and, further, that the empirical formula defined by Willstatter, repeatedly called into question by subsequent investigators, has stood the test of time. For some period after this solid foundation had been laid by Willstatter there was little activity until three new groups took the field late in the 1920s. Stoll, who had played a prominent role in the early studies as a collaborator of Willstatter, took up the work anew, and made important contributions, as did Conant in the United States. But by far the greatest contribution was made by Hans Fischer and his collaborators at Munich. Fresh from his dramatic conquest of the blood pigment, Fischer hurled his legions into the attack on chlorophyll, and during a period of approximately fifteen years, built a monumental corpus of fact. As this chemical record, almost unique in its scope and depth, was constructed, the molecule was transformed and rent asunder in innumerable directions, and the fascination and intricacy of the chemistry of chlorophyll and its congeners was fully revealed. These massive contributions were crowned by the proposal, in 1940, of a structure which was complete except for stereochemical detail. Finally, in a series of elegant investigations completed only during the last few years, Linstead and his associates at Imperial College were able to solve the stereochemical problem and to provide definitive confirmatory detail in respect of the number and disposition of saturated carbon atoms within the nuclear framework. Half a century of structural study had culminated in the complete formula (I) for chlorophyll aI, 8. Our active interest in chlorophyll was initiated four years ago, in 1956. The first questions we asked were very general ones. The structural investigations had been carried out almost entirely during the twilight of the classical period of organic chemistry. Only the very simplest basic * A brief communication recording the results on which this lecture is based has appeared in

Chlorophyll a, the major green pigment of the plant world, is certainly the most widespread and conspicuous of organic natural products. Few can be unaware of its decorative function, and all are beneficiaries of its central role in transforming sunlight into substance and sustenance. Yet the fruitful chemical study of this green badge of life did not commence until fairly recent times. For chlorophyll a is a very reactive, sensitive, and complicated substance. Only when, early in this century, the genius of Willstatter applied itself to the problem, were the first sure steps taken. That great investigator isolated the pigment-and its closely related frequent minor concomitant chlorophyll b as well-in the pure state, established correctly the empirical formula of the substance, and laid down a sound and extensive preliminary basis of transformation and degradation. These achievements can be measured against the fact that the isolation of chlorophyll in a state of purity is even now, after more than fifty years, no mean feat, and, further, that the empirical formula defined by Willstatter, repeatedly called into question by subsequent investigators, has stood the test of time. For some period after this solid foundation had been laid by Willstatter there was little activity until three new groups took the field late in the 1920s. Stoll, who had played a prominent role in the early studies as a collaborator of Willstatter, took up the work anew, and made important contributions, as did Conant in the United States. But by far the greatest contribution was made by Hans Fischer and his collaborators at Munich. Fresh from his dramatic conquest of the blood pigment, Fischer hurled his legions into the attack on chlorophyll, and during a period of approximately fifteen years, built a monumental corpus of fact. As this chemical record, almost unique in its scope and depth, was constructed, the molecule was transformed and rent asunder in innumerable directions, and the fascination and intricacy of the chemistry of chlorophyll and its congeners was fully revealed. These massive contributions were crowned by the proposal, in 1940, of a structure which was complete except for stereochemical detail. Finally, in a series of elegant investigations completed only during the last few years, Linstead and his associates at Imperial College were able to solve the stereochemical problem and to provide definitive confirmatory detail in respect of the number and disposition of saturated carbon atoms within the nuclear framework. Half a century of structural study had culminated in the complete formula (I) for chlorophyll aI, 8. Our active interest in chlorophyll was initiated four years ago, in 1956. The first questions we asked were very general ones. The structural investigations had been carried out almost entirely during the twilight of the classical period of organic chemistry. Only the very simplest basic * A brief communication recording the results on which this lecture is based has appeared in

5-(2,4-Difluorophenyl)salicylic acid, diflunisal (25), is the best compound, in terms of both efficacy and safety, from over 500 salicylates investigated in our laboratories. It is a chemically distinct, nonacetylating salicylic acid, more active than aspirin as an analgesic and antiinflammatory agent and superior in duration of action and therapeutic index. Some recent clinical and biochemical observations are briefly discussed.

A note on versions:The version presented here may differ from the published version or from the version of record. If you wish to cite this item you are advised to consult the publisher's version. Please see the repository url above for details on accessing the published version and note that access may require a subscription.For more information, please contact eprints@nottingham.ac.uk

A series of analogues of acyclovir and ganciclovir were prepared in which conformational constraints were imposed by incorporation of a cyclopropane ring or unsaturation into the side chain. In addition, several related base-modified compounds were synthesized. These acyclonucleosides were evaluated for enzymatic phosphorylation and DNA polymerase inhibition in a staggered assay and for inhibitory activity against herpes simplex virus types 1 and 2 in vitro. Certain of the guanine or 8-azaguanine derivatives were good substrates for the viral thymidine kinase and were further converted to triphosphate, but none was a potent inhibitor of the viral DNA polymerase. Nevertheless, one member of this group, (+/-)-9-[[(Z)-2-(hydroxymethyl)cyclopropyl]methyl]guanine (3a), displayed significant antiherpetic activity in vitro, superior to that of the corresponding cis olefin 4a. Another group, typified by (+/-)-9-[[(E)-2-(hydroxymethyl)cyclopropyl]methyl]adenine (17b), possessed modest antiviral activity despite an apparent inability to be enzymatically phosphorylated. The relationship of side-chain conformation and flexibility to biological activity in this series is discussed.

No abstract

The preparation, purification, and properties of various dihydrides of nitrogenous heterocycles are summarised and their reactions with chloranil described. 1,Z-Dihydro-l-methylquinoline with chloranil yields a '' phenol salt; " this is a model system for biological enzymic reduction by diphosphopyridine nucleotide (DPNH,) .H

I Diflunisal (MK-647; 5-(2,4-difluorophenyl)-salicylic acid) is a new analgesic anti-inflammatory agent discovered after an extensive chemical and pharmacological study from 1962-71. 2 In the search for a superior salicylate our objectives were higher potency, better tolerance, and a longer duration of action. 3 An evaluation of many available and newly synthesized salicylates, in the granuloma and carrageenan foot oedema assays, revealed the activity-enhancing trend of a hydrophobic group-for example, phenyl, at the carbon-5 position of salicylic acid. 4 The attachment of a 5-(4-fluorophenyl) group, previously found to enhance the potency of antiinflammatory (3,2-c)-pyrazole steroids and phenyl-a-propionic acids to acetyl salicylic acid yielded a clinical candidate flufenisal. As an analgesic, flufenisal is two times more potent than aspirin in man, but with a longer action; no distinct advantage in gastrointestinal tolerance has, however, been observed. 5 Further investigation of 5-heteroaryl salicylic acids, flufenisal congeners and their non-acylating carbonate esters identified diflunisal and 5-( l-pyrryl)-salicylic acid for subacute safety assessment. The O-acetyl group, commonly present in aspirin, benorylate and flufenisal, was purposely avoided in these two compounds for safety considerations. 6 Without an O-acetyl group, diflunisal cannot acetylate proteins and macro-molecules in vivo as aspirin does. In the prostaglandin synthetase assay in vitro, salicylic acid is much less active than aspirin. In contrast, the non-acetylated diflunisal and desacetyl flufenisal are both more active than flufenisal in vitro. A significant difference between aspirin and diflunisal in their biochemical mechanisms was noted. 7 On the basis of overall efficacy and tolerance data, diflunisal was finally chosen as a superior analgesic anti-inflammatory salicylate for clinical evaluation.